Episode Details
Back to Episodes
269: Biotech layoffs, eye drug drama, & gene therapy milestones
Published 3 years, 2 months ago
Description
First, we discuss how some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.